HYDERABAD (Reuters) – U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert A. Bradway said at the inauguration of the site.
(Reporting by Rishika Sadam, writing by Pushkala Aripaka)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibility for its content.